Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Steinherz

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Pediatrician|January 1, 1991
Delayed cardiac toxicity from anthracycline therapyL Steinherz, P Steinherz
Medical and Pediatric Oncology|January 1, 1981
Phase I trial of rubidazone (NSC 164011) in children with cancerC T Tan, S K Mitta, L Steinherz, et al.
Chest|September 1, 1977
Membranous subaortic stenosis and patent ductus arteriosusL Steinherz, K H Ehlers, A R Levin, et al.
Cancer|November 15, 1993
Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse. The Memorial Sloan-Kettering-New York-II protocolP G Steinherz, A Redner, L Steinherz, et al.
Cancer Treatment Reports|December 1, 1987
Phase I trial of homoharringtonine in children with refractory leukemiaC T Tan, E Luks, D M Bacha, et al.
Cancer|August 26, 1998
A Phase II clinical trial of idarubicin administered to children with relapsed brain tumorsC A Arndt, M D Krailo, L Steinherz, et al.
Cancer Research|June 1, 1987
Phase I and clinical pharmacological study of 4-demethoxydaunorubicin (idarubicin) in children with advanced cancerC T Tan, C Hancock, P Steinherz, et al.
Journal of Pediatric Surgery|June 1, 1994
A prospective randomized double-blind trial of bolus urokinase in the treatment of established Hickman catheter sepsis in childrenM P La Quaglia, C Caldwell, A Lucas, et al.
Medical and Pediatric Oncology|January 1, 1992
Determination of the maximum tolerated dose of idarubicin when used in a combination chemotherapy program of reinduction of childhood ALL at first marrow relapse and a preliminary assessment of toxicity compared to that of daunorubicin: a report from the Childrens Cancer Study GroupS A Feig, M D Krailo, R E Harris, et al.
Medical and Pediatric Oncology|December 1, 1996
Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer GroupS A Feig, M M Ames, H N Sather, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Pediatrician|January 1, 1991
Delayed cardiac toxicity from anthracycline therapyL Steinherz, P Steinherz
Medical and Pediatric Oncology|January 1, 1981
Phase I trial of rubidazone (NSC 164011) in children with cancerC T Tan, S K Mitta, L Steinherz, et al.
Chest|September 1, 1977
Membranous subaortic stenosis and patent ductus arteriosusL Steinherz, K H Ehlers, A R Levin, et al.
Cancer|November 15, 1993
Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse. The Memorial Sloan-Kettering-New York-II protocolP G Steinherz, A Redner, L Steinherz, et al.
Cancer Treatment Reports|December 1, 1987
Phase I trial of homoharringtonine in children with refractory leukemiaC T Tan, E Luks, D M Bacha, et al.
Cancer|August 26, 1998
A Phase II clinical trial of idarubicin administered to children with relapsed brain tumorsC A Arndt, M D Krailo, L Steinherz, et al.
Cancer Research|June 1, 1987
Phase I and clinical pharmacological study of 4-demethoxydaunorubicin (idarubicin) in children with advanced cancerC T Tan, C Hancock, P Steinherz, et al.
Journal of Pediatric Surgery|June 1, 1994
A prospective randomized double-blind trial of bolus urokinase in the treatment of established Hickman catheter sepsis in childrenM P La Quaglia, C Caldwell, A Lucas, et al.
Medical and Pediatric Oncology|January 1, 1992
Determination of the maximum tolerated dose of idarubicin when used in a combination chemotherapy program of reinduction of childhood ALL at first marrow relapse and a preliminary assessment of toxicity compared to that of daunorubicin: a report from the Childrens Cancer Study GroupS A Feig, M D Krailo, R E Harris, et al.
Medical and Pediatric Oncology|December 1, 1996
Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer GroupS A Feig, M M Ames, H N Sather, et al.
Pageof 1